Wassie, Molla M.
Dix, Maddison
Laven-Law, Geraldine
Bulamu, Norma
Cock, Charles
Bampton, Peter
Fraser, Robert J.
Winter, Jean M.
Young, Graeme P.
Symonds, Erin L.
Funding for this research was provided by:
National Health and Medical Research Council (2009050)
Cancer Council South Australia
Flinders Foundation
Flinders University
Article History
Received: 6 March 2024
Accepted: 23 April 2024
First Online: 16 May 2024
Declarations
:
: Authors GPY and ELS have previously received funding and consumables for investigator-led studies from Eiken Chemical Company (Japan). ELS is a member of a committee to standardize the analysis of FIT samples.
: The study was approved by the Southern Adelaide Human Research Ethics Committee (Approval Number #422.13 and #330.17 for participants offered FIT and surveys, respectively). Studies were registered with the Australian and New Zealand Clinical Trials Registry (ACTRN #12618001406291 and #12618001277235, respectively). Written informed consent was provided from participants accompanying return of completed FIT and surveys.